Form 4 for REGN Regeneron Pharmaceuticals
Accepted 2025-11-10 00:00:00 ET · period of report 2025-11-07 · accession 0002009236-25-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-10 | 2025-11-07 | REGN | Pitofsky Jason | VP Ctrl | S - Sale | $651.43 | -431 | 4,233 | -9% | -$280.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-07 | S | D | 431 | $651.43 | 4,233 | D | — | — |